🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
There is no cure for HIV infection. Antiretroviral therapy (ART) is widely ...
Status
Recruiting
Location
Guys and St Thomas' NHS Trust
Start Date
2025-09-05
Trial ID
NCT07054931
The increase in pediatric HIV infection has a substantial impact on childho...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00639938
Treatments Being Tested
This study evaluates the safety, tolerability, and pharmacokinetics (PK) of...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2024-10-02
Trial ID
NCT06652958
Treatments Being Tested
Antibodies are natural proteins that the body makes to fight infections. An...
Status
Completed
Location
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
Start Date
2014-08
Trial ID
NCT02165267
Treatments Being Tested
RHIVIERA-02 trial is a placebo-controlled double-blinded two arm prospectiv...
Status
Recruiting
Location
Hôpial Avicenne - SMIT
Start Date
2024-04-11
Trial ID
NCT05300035
Treatments Being Tested
This phase II trial studies how well combination chemotherapy with or witho...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2013-09-06
Trial ID
NCT01959672
The goal of the proposed research is to 1) examine the performance of emerg...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Start Date
2024-12-16
Trial ID
NCT06628570
Treatments Being Tested
This study is to evaluate antiviral activity, efficacy, safety, tolerabilit...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-22
Trial ID
NCT04871113
Treatments Being Tested
This randomized, placebo controlled trial will evaluate the safety and immu...
Status
Completed
Location
RMPRU, Chris Hani Baragwanath Hospital
Start Date
2011-03
Trial ID
NCT01306682
Treatments Being Tested